Refining the Molecular Framework for Pancreatic Cancer with Single-cell and Spatial Technologies

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Pancreatic ductal adenocarcinoma (PDAC) is a difficult-to-treat cancer lacking specific molecular guidance for therapies.
• Current bulk transcriptomic studies identify two subtypes but don't tailor treatments.
• Distinguishing tumor cells from the microenvironment in PDAC is challenging with bulk methods.

Purpose of the Study:

• To explore the potential of single-cell and spatial transcriptomics in advancing pancreatic cancer research.
• To overcome limitations of bulk RNA studies in PDAC, particularly regarding intratumoral heterogeneity and microenvironment interactions.
• To identify therapeutic strategies by analyzing gene programs in response to neoadjuvant therapy.

Main Methods:

• Application of single-cell transcriptomics to analyze pancreatic tumors at a granular level.
• Utilizing spatially resolved technologies to contextualize gene expression within tumor architecture.
• Investigating gene programs induced by neoadjuvant chemotherapy and chemoradiotherapy.

Main Results:

• Single-cell studies reveal intratumoral heterogeneity and malignant-stromal interactions previously obscured.
• Spatial technologies enable contextualization of gene programs and cell-cell interactions.
• Emerging data highlights the importance of understanding therapy-induced gene programs.

Conclusions:

• Single-cell and spatial technologies provide unprecedented resolution for PDAC molecular profiling.
• These advanced techniques can refine existing knowledge from bulk studies.
• Precision oncology efforts in pancreatic cancer can be significantly augmented by these technologies.